Source: Optimi Health
  • Optimi Health (OPTI) has finalized three new Canadian retail and e-commerce distribution agreements for its Optimi Life nutraceutical mushroom products
  • After its online launch of its mushroom supplements online in February, the company made agreements with Well.ca, Vitasave, and Healthy Planet to sell its line of functional mushroom supplements
  • Optimi Health (OPTI) is down 3.80 per cent trading at C$0.38 as of 10:00 am ET

Optimi Health (OPTI) has finalized three new Canadian retail and e-commerce distribution agreements for its Optimi Life nutraceutical mushroom products.

After its online launch of its mushroom supplements online in February, the company made agreements with Well.ca, Vitasave, and Healthy Planet to sell its line of functional mushroom supplements.

Well.ca is a natural foods e-commerce platform, while Vitasave has two retail outlets and an e-commerce platform, and Healthy Planet has a web-based selling platform as well as more than 30 retail locations across Ontario.

Optimi CEO, Bill Ciprick, said the agreements strengthen the company’s business-to-business distribution network and positions the Optimi Life brand for expansion into international markets.

“With the global functional mushroom market estimated to grow 9.5 per cent annually over the next six years, we’ll be actively positioning the Optimi Life brand throughout Canada as well as in international markets.”

Optimi Health (OPTI) is a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and synthetic psychedelic substances, as well as functional mushrooms that focus on the health and wellness markets

Optimi Health (OPTI) is down 3.80 per cent trading at C$0.38 as of 10:00 am ET.


More From The Market Online

CCrest Labs receives Red Light Holland’s largest psilocybin order

Red Light Holland's (CSE:TRIP) largest shipment to date of 5 kilograms of psilocybin truffles has been received by CCrest Labs in Montreal.

Red Light Holland reports record psilocybin shipment

Psychedelics stock Red Light Holland (CSE:TRIP) exports 5 kilograms of natural psilocybin truffles to CCrest Laboratories in Montreal.

Psychedelic stock begins take-home LSD microdosing clinical trial

MindBio Therapeutics (CSE:MBIO) secures approvals for MB22001 – a form of LSD – microdosing use by patients in a controlled clinical trial.

Red Light Holland begins experimental research on psilocybin truffles

Red Light Holland has revealed that it has officially begun an experimental research project on its psilocybin truffles.